Arjun Balachandar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Arjun Balachandar has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Alfonso Fasano
Department of Biomedical Sciences Humanitas University Milan Italy
8 shared publications Suneil K. Kalia
Krembil Brain Institute Toronto Ontario Canada
4 shared publications- Alexandre Boutet
University of Toronto
3 shared publications Andres M. Lozano
Krembil Brain Institute Toronto Ontario Canada
3 shared publicationsJurgen Germann
Division of Neurosurgery, Department of Surgery University of Toronto Toronto Ontario Canada
3 shared publicationsAlfonso Fasano
Department of Medicine University of Toronto Toronto Ontario Canada
2 shared publications
Latest Publications
- 20 April 2026
- Published by Springer Nature in Nature Reviews Bioengineering
- Vol. 4 (7) , 636-652
Neuromodulation for gait disorders
- 20 April 2026
- Published by Springer Nature in Nature Reviews Bioengineering
- Vol. 4 (7) , 636-652
Neuromodulation for gait disorders
- Open Access
- 5 March 2026
- Published by Wiley in Movement Disorders
- Vol. 41 (6) , 1349-1354
Beyond the Homunculus— SCAN ‐ AMN as a Shared Action‐Oriented Neural Substrate across Movement Disorders
- 5 March 2026
- Published by Wiley in Movement Disorders
- Vol. 41 (6) , 1349-1354
Open AccessBeyond the Homunculus— SCAN ‐ AMN as a Shared Action‐Oriented Neural Substrate across Movement Disorders
- Open Access
- 14 January 2026
- Published by Wiley in Movement Disorders
- Vol. 41 (4) , 1028-1033
Beta‐Band and Aperiodic Activity Across New and Chronic Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
Background: Neurophysiological biomarkers in Parkinson's disease (PD) are increasingly used for deep brain stimulation (DBS). Their long‐term utility is not clear, especially when transitioning to sensing‐guided DBS years post‐surgery. Objectives: Beta‐band power, bursting activity, and periodic and aperiodic components of local field potentials recorded from DBS electrodes in the subthalamic nucleus (STN) were compared between a group of newly and chronically (6.7 ± 4.0 years) implanted PD patients. Clinical severity was rated using the Movement Disorder Society‐Unified Parkinson's Disease Rating Scale‐Part III (MDS‐UPDRS‐III). Results: Beta‐band power and burst amplitude were significantly higher and aperiodic offset and exponent were significantly lower in the chronically implanted cohort. Periodic peak frequency and power were not significantly different. Clinical severity correlated with cumulative burst time and burst rate. A longitudinal subset showed no change in peak frequency or power. Conclusions: STN beta‐band‐related biomarkers inform disease state of de novo and chronic PD‐DBS cohorts, with signal properties relevant for sensing‐guided DBS preserved over time. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
- 14 January 2026
- Published by Wiley in Movement Disorders
- Vol. 41 (4) , 1028-1033
Open AccessBeta‐Band and Aperiodic Activity Across New and Chronic Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
Background: Neurophysiological biomarkers in Parkinson's disease (PD) are increasingly used for deep brain stimulation (DBS). Their long‐term utility is not clear, especially when transitioning to sensing‐guided DBS years post‐surgery. Objectives: Beta‐band power, bursting activity, and periodic and aperiodic components of local field potentials recorded from DBS electrodes in the subthalamic nucleus (STN) were compared between a group of newly and chronically (6.7 ± 4.0 years) implanted PD patients. Clinical severity was rated using the Movement Disorder Society‐Unified Parkinson's Disease Rating Scale‐Part III (MDS‐UPDRS‐III). Results: Beta‐band power and burst amplitude were significantly higher and aperiodic offset and exponent were significantly lower in the chronically implanted cohort. Periodic peak frequency and power were not significantly different. Clinical severity correlated with cumulative burst time and burst rate. A longitudinal subset showed no change in peak frequency or power. Conclusions: STN beta‐band‐related biomarkers inform disease state of de novo and chronic PD‐DBS cohorts, with signal properties relevant for sensing‐guided DBS preserved over time. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
- 11 November 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 105 (9) , e214201
Surgical Complications of Deep Brain Stimulation in Children Across Targets and Indications
Deep brain stimulation (DBS) is considered off-label and investigational in pediatric populations with some exceptions. There are limited data on the relative rates of complications after DBS across different indications and targets in children. This study aimed to evaluate the safety of DBS surgery for children with movement disorders (MDs; dystonia, chorea, or tic disorders), drug-resistant epilepsy (DRE), or neurodevelopmental disorders, namely, self-injurious behavior (SIB). Data were collected both prospectively and retrospectively from children implanted with DBS through the North American multicenter Child and Youth CompreHensIve Longitudinal Database for Deep Brain Stimulation and included demographic, clinical, operative, and postoperative variables. Complications included infection, noninfectious surgical site findings (dehiscence or seroma), hardware-related issues (disconnection or impedance change), intracranial injury, or other complications. The primary outcome was major complications, defined as any adverse event causing permanent neurologic injury or requiring surgical intervention. The secondary outcome was minor complications, defined as nonmajor complications. Generalized linear models were used to assess for any significant associations with complications. A total of 130 children and youth (mean age 12.2 ± 4.2; range 3-18) years and weighing 12.5-126.6 kg underwent DBS. The most common indication was MD (77, 59.2%), followed by DRE (47, 36.2%) and SIB (6, 4.6%). Major complications occurred in 11.5%, with a greater likelihood in MD (n = 12, 15.6%) compared with DRE (n = 2, 4.3%; odds ratio [OR] 3.55, 95% CI 2.66-4.73, p < 0.001) and significantly associated with lower weight at surgery (p < 0.001) and urgent intervention (p = 0.028). These included infection (6.2%), hardware malfunction (3.1%), and wound dehiscence (0.8%). Minor complications were also higher with MD compared with DRE (OR 1.83, 95% CI 1.16-2.89, p = 0.010) occurring in 22 participants (16.9%; 14 MD, 7 DRE, 1 SIB), including infection (6.2%), high impedance (1.5%), unrelated hydrocephalus (0.8%), perioperative worsening of symptoms (3.8%), incidental tract hemorrhage (2.3%), and noninfectious peri-electrode cystic changes (0.8%). DBS-associated complications were low across multiple pediatric indications and targets, with MD associated with higher risk of major complications. Limitations include a focus on surgical postoperative complications and not stimulation-related adverse outcomes. These findings demonstrate the safety profile of DBS in children in a large cohort.
- 11 November 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 105 (9) , e214201
Surgical Complications of Deep Brain Stimulation in Children Across Targets and Indications
Deep brain stimulation (DBS) is considered off-label and investigational in pediatric populations with some exceptions. There are limited data on the relative rates of complications after DBS across different indications and targets in children. This study aimed to evaluate the safety of DBS surgery for children with movement disorders (MDs; dystonia, chorea, or tic disorders), drug-resistant epilepsy (DRE), or neurodevelopmental disorders, namely, self-injurious behavior (SIB). Data were collected both prospectively and retrospectively from children implanted with DBS through the North American multicenter Child and Youth CompreHensIve Longitudinal Database for Deep Brain Stimulation and included demographic, clinical, operative, and postoperative variables. Complications included infection, noninfectious surgical site findings (dehiscence or seroma), hardware-related issues (disconnection or impedance change), intracranial injury, or other complications. The primary outcome was major complications, defined as any adverse event causing permanent neurologic injury or requiring surgical intervention. The secondary outcome was minor complications, defined as nonmajor complications. Generalized linear models were used to assess for any significant associations with complications. A total of 130 children and youth (mean age 12.2 ± 4.2; range 3-18) years and weighing 12.5-126.6 kg underwent DBS. The most common indication was MD (77, 59.2%), followed by DRE (47, 36.2%) and SIB (6, 4.6%). Major complications occurred in 11.5%, with a greater likelihood in MD (n = 12, 15.6%) compared with DRE (n = 2, 4.3%; odds ratio [OR] 3.55, 95% CI 2.66-4.73, p < 0.001) and significantly associated with lower weight at surgery (p < 0.001) and urgent intervention (p = 0.028). These included infection (6.2%), hardware malfunction (3.1%), and wound dehiscence (0.8%). Minor complications were also higher with MD compared with DRE (OR 1.83, 95% CI 1.16-2.89, p = 0.010) occurring in 22 participants (16.9%; 14 MD, 7 DRE, 1 SIB), including infection (6.2%), high impedance (1.5%), unrelated hydrocephalus (0.8%), perioperative worsening of symptoms (3.8%), incidental tract hemorrhage (2.3%), and noninfectious peri-electrode cystic changes (0.8%). DBS-associated complications were low across multiple pediatric indications and targets, with MD associated with higher risk of major complications. Limitations include a focus on surgical postoperative complications and not stimulation-related adverse outcomes. These findings demonstrate the safety profile of DBS in children in a large cohort.
- Open Access
- 22 October 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-15
Status dystonicus is a distinct state characterized by pallidal beta-band activity
Status dystonicus (SD) is a poorly known neurological emergency requiring urgent interventions, including deep brain stimulation (DBS) targeting the globus pallidus interna (GPi). The sensing capabilities of DBS electrodes provide an opportunity to study the pathophysiology of SD. Here, we study local field potentials (LFPs) from GPi-DBS electrodes implanted in a cohort of 10 children longitudinally during SD, recovery and relapse (recording range 11-1155 days). During SD, we report an increase in the periodic component of the power spectrum within the beta-band along with increases in burst amplitude compared to recordings in non-SD states. Furthermore, relapsed SD is characterized by a return of excessive beta signatures. Beta-specific LFP power is also significantly associated with worse quality-of-life scores (PedsQL, R2 = 0.695). We identify circadian pallidal beta-band periodicity in one participant with chronic narrowband beta-power recordings over months, with significant increase in power during SD. These rare recordings in children with SD point to excessive pallidal beta-band activity as a biomarker of SD. Our findings further suggest that SD is a distinct state with important implications for understanding dystonia pathophysiology, tracking dystonia states from intracranial activity and potential adaptive DBS treatments.
- 22 October 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-15
Open AccessStatus dystonicus is a distinct state characterized by pallidal beta-band activity
Status dystonicus (SD) is a poorly known neurological emergency requiring urgent interventions, including deep brain stimulation (DBS) targeting the globus pallidus interna (GPi). The sensing capabilities of DBS electrodes provide an opportunity to study the pathophysiology of SD. Here, we study local field potentials (LFPs) from GPi-DBS electrodes implanted in a cohort of 10 children longitudinally during SD, recovery and relapse (recording range 11-1155 days). During SD, we report an increase in the periodic component of the power spectrum within the beta-band along with increases in burst amplitude compared to recordings in non-SD states. Furthermore, relapsed SD is characterized by a return of excessive beta signatures. Beta-specific LFP power is also significantly associated with worse quality-of-life scores (PedsQL, R2 = 0.695). We identify circadian pallidal beta-band periodicity in one participant with chronic narrowband beta-power recordings over months, with significant increase in power during SD. These rare recordings in children with SD point to excessive pallidal beta-band activity as a biomarker of SD. Our findings further suggest that SD is a distinct state with important implications for understanding dystonia pathophysiology, tracking dystonia states from intracranial activity and potential adaptive DBS treatments.
- Open Access
- 19 May 2025
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 12 (9) , 1410-1414
Cerebellar Dentate Cavernoma Enlargement and Tremor Emergence: Longitudinal Neuroimaging Analysis of Case Report and Literature Review
- 19 May 2025
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 12 (9) , 1410-1414
Open AccessCerebellar Dentate Cavernoma Enlargement and Tremor Emergence: Longitudinal Neuroimaging Analysis of Case Report and Literature Review
- Open Access
- 19 February 2025
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 12 (6) , 858-859
Misophonia in Tic Disorders and Their Neuropsychiatric Associations
- 19 February 2025
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 12 (6) , 858-859
Open AccessMisophonia in Tic Disorders and Their Neuropsychiatric Associations
- Open Access
- 23 August 2024
- Published by Wiley in Movement Disorders
- Vol. 39 (11) , 2097-2102
Automated Sleep Detection in Movement Disorders Using Deep Brain Stimulation and Machine Learning
Background: Automated sleep detection in movement disorders may allow monitoring sleep, potentially guiding adaptive deep brain stimulation (DBS).Objectives: The aims were to compare wake‐versus‐sleep status (WSS) local field potentials (LFP) in a home environment and develop biomarkers of WSS in Parkinson's disease (PD), essential tremor (ET), and Tourette's syndrome (TS) patients.Methods: Five PD, 2 ET, and 1 TS patient were implanted with Medtronic Percept (3 STN [subthalamic nucleus], 3 GPi [globus pallidus interna], and 2 ventral intermediate nucleus). Over five to seven nights, β‐band (12.5–30 Hz) and/or α‐band (7–12 Hz) LFP power spectral densities were recorded. Wearable actigraphs tracked sleep.Results: From sleep to wake, PD LFP β‐power increased in STN and decreased in GPi, and α‐power increased in both. Machine learning classifiers were trained. For PD, the highest WSS accuracy was 93% (F1 = 0.93), 86% across all patients (F1 = 0.86). The maximum accuracy was 86% for ET and 89% for TS.Conclusion: Chronic intracranial narrowband recordings can accurately identify sleep in various movement disorders and targets in this proof‐of‐concept study. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
- 23 August 2024
- Published by Wiley in Movement Disorders
- Vol. 39 (11) , 2097-2102
Open AccessAutomated Sleep Detection in Movement Disorders Using Deep Brain Stimulation and Machine Learning
Background: Automated sleep detection in movement disorders may allow monitoring sleep, potentially guiding adaptive deep brain stimulation (DBS).Objectives: The aims were to compare wake‐versus‐sleep status (WSS) local field potentials (LFP) in a home environment and develop biomarkers of WSS in Parkinson's disease (PD), essential tremor (ET), and Tourette's syndrome (TS) patients.Methods: Five PD, 2 ET, and 1 TS patient were implanted with Medtronic Percept (3 STN [subthalamic nucleus], 3 GPi [globus pallidus interna], and 2 ventral intermediate nucleus). Over five to seven nights, β‐band (12.5–30 Hz) and/or α‐band (7–12 Hz) LFP power spectral densities were recorded. Wearable actigraphs tracked sleep.Results: From sleep to wake, PD LFP β‐power increased in STN and decreased in GPi, and α‐power increased in both. Machine learning classifiers were trained. For PD, the highest WSS accuracy was 93% (F1 = 0.93), 86% across all patients (F1 = 0.86). The maximum accuracy was 86% for ET and 89% for TS.Conclusion: Chronic intracranial narrowband recordings can accurately identify sleep in various movement disorders and targets in this proof‐of‐concept study. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
- 16 August 2024
- Published by Wiley in Movement Disorders
- Vol. 39 (10) , 1729-1730
Frequency Coding in Essential Tremor—The Olivocerebellar Orchestra Conducts Its Own Symphony
- 16 August 2024
- Published by Wiley in Movement Disorders
- Vol. 39 (10) , 1729-1730
Frequency Coding in Essential Tremor—The Olivocerebellar Orchestra Conducts Its Own Symphony
- Open Access
- 16 February 2023
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 10 (3) , 529-530
Reply to: Glioblastoma, IDH‐Wildtype, CNS WHO Grade 4, Associated with Deep Brain Stimulation in a Patient with Essential Tremor: Report of a Case with Molecular Characterization and Review of the Literature
- 16 February 2023
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 10 (3) , 529-530
Open AccessReply to: Glioblastoma, IDH‐Wildtype, CNS WHO Grade 4, Associated with Deep Brain Stimulation in a Patient with Essential Tremor: Report of a Case with Molecular Characterization and Review of the Literature